Meyka Pro banner
DocGo Inc.

DocGo Inc. Fundamental Analysis (NASDAQ: DCGO)

DCGONASDAQ
HealthcareMedical - Care Facilities
$0.43
$0.010(2.35%)
U.S. Market opens in 15h 38m

DocGo Inc. Fundamental Analysis (NASDAQ: DCGO)

DocGo Inc. (NASDAQ: DCGO) shows weak financial fundamentals with a PE ratio of -0.22, profit margin of -65.29%, and ROE of -0.00%. The company generates $0.3B in annual revenue with weak year-over-year growth of -47.74%.

Key Strengths

Cash Position59.34%
PEG Ratio-0.01
Current Ratio1.66

Areas of Concern

ROE-0.00%
Operating Margin-37.68%
We analyze DCGO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -71.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-71.0/100

We analyze DCGO's fundamental strength across five key dimensions:

Efficiency Score

Weak

DCGO struggles to generate sufficient returns from assets.

ROA > 10%
-0.00%

Valuation Score

Excellent

DCGO trades at attractive valuation levels.

PE < 25
-0.22
PEG Ratio < 2
-0.01

Growth Score

Weak

DCGO faces weak or negative growth trends.

Revenue Growth > 5%
-47.74%
EPS Growth > 10%
-10.20%

Financial Health Score

Excellent

DCGO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.22
Current Ratio > 1
1.66

Profitability Score

Weak

DCGO struggles to sustain strong margins.

ROE > 15%
-0.06%
Net Margin ≥ 15%
-65.29%
Positive Free Cash Flow
No

Key Financial Metrics

Is DCGO Expensive or Cheap?

P/E Ratio

DCGO trades at -0.22 times earnings. This suggests potential undervaluation.

-0.22

PEG Ratio

When adjusting for growth, DCGO's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values DocGo Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -39630.39 times EBITDA. This is generally considered low.

-39630.39

How Well Does DCGO Make Money?

Net Profit Margin

For every $100 in sales, DocGo Inc. keeps $-65.29 as profit after all expenses.

-65.29%

Operating Margin

Core operations generate -37.68 in profit for every $100 in revenue, before interest and taxes.

-37.68%

ROE

Management delivers $-0.00 in profit for every $100 of shareholder equity.

-0.00%

ROA

DocGo Inc. generates $-0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.00%

Following the Money - Real Cash Generation

Operating Cash Flow

DocGo Inc. generates limited operating cash flow of $-22.70M, signaling weaker underlying cash strength.

$-22.70M

Free Cash Flow

DocGo Inc. generates weak or negative free cash flow of $-27.14M, restricting financial flexibility.

$-27.14M

FCF Per Share

Each share generates $-0.27 in free cash annually.

$-0.27

FCF Yield

DCGO converts -66.73% of its market value into free cash.

-66.73%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.22

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.16

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How DCGO Stacks Against Its Sector Peers

MetricDCGO ValueSector AveragePerformance
P/E Ratio-0.2231.70 Better (Cheaper)
ROE-115.58%448.00% Weak
Net Margin-65.29%22837.00% Weak
Debt/Equity0.220.54 Strong (Low Leverage)
Current Ratio1.665.63 Neutral
ROA-0.00%-49.00% (disorted) Weak

DCGO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DocGo Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

246.41%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1184.97%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

427.11%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ